Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenomiX4U is a Greece-based genomics startup focused on making genomic analysis accessible for personalized health and lifestyle applications. The company offers saliva-based genetic testing services that support treatment individualization and consumer-oriented genomic insights, including taste-related profiling for products such as wine, oil, and coffee. Its health-related positioning includes pharmacogenomic testing aimed at personalizing drug use, with particular emphasis on statin treatment and reducing adverse drug reactions. GenomiX4U also highlights the use of a portable molecular biology laboratory to deliver services with fewer location constraints. Overall, the company appears to operate as an early-stage commercial genomics and personalized medicine services business rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GenomiX4U.